No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

Jane Warwick; Emanuela Falaschetti; Kenneth Rockwood; Arnold Mitnitski; Lutgarde Thijs; Nigel Beckett; Christopher Bulpitt; Ruth Peters

No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

Jane Warwick, Emanuela Falaschetti, Kenneth Rockwood, Arnold Mitnitski, Lutgarde Thijs, Nigel Beckett, Christopher Bulpitt, Ruth Peters

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	BMC Medicine
Volume	13
Issue number	1
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Warwick, J., Falaschetti, E., Rockwood, K., Mitnitski, A., Thijs, L., Beckett, N., Bulpitt, C., & Peters, R. (2015). No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Medicine, 13(1).

Warwick, Jane ; Falaschetti, Emanuela ; Rockwood, Kenneth et al. / No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. In: BMC Medicine. 2015 ; Vol. 13, No. 1.

@article{a6cbb94b796e451ea3a8e6975995e36b,

title = "No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over",

author = "Jane Warwick and Emanuela Falaschetti and Kenneth Rockwood and Arnold Mitnitski and Lutgarde Thijs and Nigel Beckett and Christopher Bulpitt and Ruth Peters",

year = "2015",

language = "English",

volume = "13",

journal = "BMC Medicine",

publisher = "Springer Nature",

number = "1",

}

Warwick, J, Falaschetti, E, Rockwood, K, Mitnitski, A, Thijs, L, Beckett, N, Bulpitt, C & Peters, R 2015, 'No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over', BMC Medicine, vol. 13, no. 1.

No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. / Warwick, Jane; Falaschetti, Emanuela; Rockwood, Kenneth et al.
In: BMC Medicine, Vol. 13, No. 1, 2015.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over

AU - Warwick, Jane

AU - Falaschetti, Emanuela

AU - Rockwood, Kenneth

AU - Mitnitski, Arnold

AU - Thijs, Lutgarde

AU - Beckett, Nigel

AU - Bulpitt, Christopher

AU - Peters, Ruth

PY - 2015

Y1 - 2015

M3 - Article

VL - 13

JO - BMC Medicine

JF - BMC Medicine

IS - 1

ER -

Warwick J, Falaschetti E, Rockwood K, Mitnitski A, Thijs L, Beckett N et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Medicine. 2015;13(1).